JP2004536605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536605A5 JP2004536605A5 JP2003515633A JP2003515633A JP2004536605A5 JP 2004536605 A5 JP2004536605 A5 JP 2004536605A5 JP 2003515633 A JP2003515633 A JP 2003515633A JP 2003515633 A JP2003515633 A JP 2003515633A JP 2004536605 A5 JP2004536605 A5 JP 2004536605A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antibody according
- antibody
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30797301P | 2001-07-26 | 2001-07-26 | |
| US31227801P | 2001-08-14 | 2001-08-14 | |
| PCT/US2002/021281 WO2003010282A2 (en) | 2001-07-26 | 2002-07-18 | Interleukin-1 beta antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004536605A JP2004536605A (ja) | 2004-12-09 |
| JP2004536605A5 true JP2004536605A5 (https=) | 2006-01-05 |
Family
ID=26976031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515633A Pending JP2004536605A (ja) | 2001-07-26 | 2002-07-18 | インターロイキン１β抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050075488A1 (https=) |
| EP (1) | EP1423432A4 (https=) |
| JP (1) | JP2004536605A (https=) |
| AR (1) | AR036189A1 (https=) |
| AU (1) | AU2002355249A1 (https=) |
| PE (1) | PE20030282A1 (https=) |
| SV (1) | SV2003001183A (https=) |
| WO (1) | WO2003010282A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1481010A2 (en) * | 2002-02-28 | 2004-12-01 | Eli Lilly And Company | Anti-interleukin-1 beta analogs |
| EP1590369B1 (en) * | 2003-01-24 | 2016-03-16 | Applied Molecular Evolution, Inc. | Human il-1 beta antagonists |
| GB0303337D0 (en) * | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| US20040208876A1 (en) | 2003-04-18 | 2004-10-21 | Kim Kyung Jin | Monoclonal antibodies to hepatocyte growth factor |
| EP1851245B1 (en) * | 2005-01-26 | 2012-10-10 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| DK1899378T3 (da) | 2005-06-21 | 2010-02-01 | Xoma Technology Ltd | IL-1 beta-bindende antistoffer og fragmenter deraf |
| EP3725299A1 (en) * | 2005-06-24 | 2020-10-21 | Duke University | A direct drug delivery system based on thermally responsive biopolymers |
| TR201802449T4 (tr) * | 2005-10-26 | 2018-03-21 | Novartis Ag | Ailesel akdeniz hummasının anti ıl-1beta antikorları ile tedavisi. |
| AR059922A1 (es) | 2006-04-01 | 2008-05-07 | Galaxy Biotech Llc | Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos |
| CA2673592C (en) | 2006-12-20 | 2014-03-25 | Xoma Technology Ltd. | Methods for the treatment of il-1.beta. related diseases |
| CA2839162A1 (en) * | 2006-12-20 | 2008-06-26 | Xoma Technology Ltd. | Methods for the treatment of il-1-.beta. related diseases |
| US8637029B2 (en) * | 2007-12-20 | 2014-01-28 | Xoma Technology Ltd. | Methods for the treatment of gout |
| ES2398693T3 (es) * | 2008-06-06 | 2013-03-21 | Xoma Technology Ltd. | Métodos para el tratamiento de la artritis reumatoide |
| EP2341936A4 (en) | 2008-09-05 | 2012-07-25 | Xoma Technology Ltd | METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES |
| KR20130065662A (ko) | 2010-05-07 | 2013-06-19 | 조마 테크놀로지 리미티드 | ⅠＬ-1β 관련 병태의 치료 방법 |
| US20110307788A1 (en) * | 2010-06-15 | 2011-12-15 | Microsoft Corporation | Role-based presentation views |
| US20150017157A1 (en) | 2011-12-19 | 2015-01-15 | Xoma (Us) Llc | Methods for treating acne |
| US10436795B2 (en) * | 2016-09-16 | 2019-10-08 | Institute For Cancer Research | Carbon-detected NMR for mapping binding sites in intrinsically disordered regions of a protein |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| EP0569687B1 (en) * | 1984-05-18 | 2002-08-21 | New England Medical Center Hospitals, Inc. | Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins |
| US5484887A (en) * | 1984-06-19 | 1996-01-16 | Immunex Corporation | Homogeneous interleukin 1 |
| US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4935343A (en) * | 1986-08-08 | 1990-06-19 | Syntex (U.S.A.) Inc. | Monoclonal antibodies for interleukin-1β |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| WO1995001997A1 (en) * | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
| US20020155114A1 (en) * | 1998-08-31 | 2002-10-24 | James D. Marks | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| JP2003523724A (ja) | 1999-03-12 | 2003-08-12 | エグゼリクシス プラント サイエンシーズ， インコーポレイテッド | 形質関連遺伝子の同定方法 |
-
2002
- 2002-07-18 EP EP02752171A patent/EP1423432A4/en not_active Ceased
- 2002-07-18 AU AU2002355249A patent/AU2002355249A1/en not_active Abandoned
- 2002-07-18 JP JP2003515633A patent/JP2004536605A/ja active Pending
- 2002-07-18 WO PCT/US2002/021281 patent/WO2003010282A2/en not_active Ceased
- 2002-07-18 US US10/484,280 patent/US20050075488A1/en not_active Abandoned
- 2002-07-23 AR ARP020102764A patent/AR036189A1/es not_active Application Discontinuation
- 2002-07-24 PE PE2002000654A patent/PE20030282A1/es not_active Application Discontinuation
- 2002-07-25 SV SV2002001183A patent/SV2003001183A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004536605A5 (https=) | ||
| JP2005519580A5 (https=) | ||
| HRP20130922T1 (hr) | U potpunosti humana protutijela protiv humanog 4-1bb (cd137) | |
| IL261019A (en) | Antibodies to 6 -il and their use | |
| MY148409A (en) | Anti-mag antibodies | |
| JP2019054802A5 (https=) | ||
| EP1578799B8 (en) | Antibodies directed to tumor necrosis factor and uses thereof | |
| EP2377555A3 (en) | Antibodies against vascular endothelial growth factor receptor-1 | |
| SG151284A1 (en) | Antibodies against ccr5 and uses thereof | |
| NL300920I2 (nl) | inotuzumab ozogamicine | |
| TW200616657A (en) | Therapeutic peptides and method | |
| JP2011501945A5 (https=) | ||
| TW200716182A (en) | Antibodies directed to CD20 and uses thereof | |
| MX2011008843A (es) | Anticuerpos humanizados que se unen a cd19 y sus usos. | |
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof | |
| NZ597466A (en) | Recombinant anti-epidermal growth factor receptor antibody compositions | |
| RU2012102323A (ru) | Способ лечения ревматоидного артрита посредством лекарственного препарата на основе выделенного человеческого антитела или его антигенсвязывающего фрагмента | |
| NZ604090A (en) | Human anti-b7rp1 neutralizing antibodies | |
| NZ599683A (en) | Anti-ilt7 antibody | |
| JP2008538564A5 (https=) | ||
| NZ568403A (en) | CD20-specific antibodies and methods of employing same | |
| EP2471817A3 (en) | Humanized antibody molecules specific for IL-31 | |
| NZ593068A (en) | IL-18 antibody | |
| ATE420660T1 (de) | Antikörper gegen parath-hormon (pth) und ihre verwendungen | |
| TW200634027A (en) | Antibodies directed to angiopoietin-2 and uses thereof |